DR. TOBIN THOPPIL ABRAHAM M.D. NPI 1649683889

NPI Information

  • NPI: 1649683889
  • Provider Name: DR. TOBIN THOPPIL ABRAHAM, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1157 BROADWAY
    HEWLETT, NY
    ZIP 11557
  • Phone: (516) 295-4481

Map and Directions

Get Directions

NPI Details

DR. Tobin Thoppil Abraham, M.D. is a rheumatology internal medicine in Hewlett, NY with 12 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Tobin Thoppil Abraham, M.D. NPI is 1649683889. The provider is registered as an individual entity type and is a single specialty group.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: STATE UNIVERSITY OF NEW YORK DOWNSTATE MEDICAL CENTER
Graduation Year:2014

The provider's business location address is:

1157 BROADWAY
HEWLETT, NY
ZIP 11557-325
Phone: (516) 295-4481

The NPI 1649683889 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg (HCPCS:J7328)
  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Beta 2 glycoprotein 1 antibody (autoantibody) measurement (HCPCS:86146)
  • Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Phosphatase (enzyme) level, alkaline (HCPCS:84075)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Uric acid level, blood (HCPCS:84550)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Liver enzyme (sgot), level (HCPCS:84450)
  • Liver enzyme (sgpt), level (HCPCS:84460)
  • Phosphate level (HCPCS:84100)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Albumin (protein) level (HCPCS:82040)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Analysis for antibody to epstein-barr virus (mononucleosis virus), viral capsid (HCPCS:86665)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Thyroid hormone evaluation (HCPCS:84479)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Rheumatoid factor analysis (HCPCS:86430)
  • Vitamin d-3 level (HCPCS:82306)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Angiotensin l - converting enzyme (ace) level (HCPCS:82164)
  • Screening test for antibody to noninfectious agent (HCPCS:86255)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Immune complex measurement (HCPCS:86332)
  • Analysis for antibody borrelia burgdorferi (lyme disease bacteria) (HCPCS:86618)
  • Analysis for antibody to epstein-barr virus (mononucleosis virus), early antigen (HCPCS:86663)
  • Analysis for antibody to epstein-barr virus (mononucleosis virus), nuclear antigen (HCPCS:86664)
  • Screening test for mononucleosis (mono) (HCPCS:86308)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Measurement of antibody for assessment of autoimmune disorder, titer (HCPCS:86039)
  • Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
  • X-ray of knee, 1-2 views (HCPCS:73560)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • X-ray of hand, 2 views (HCPCS:73120)
  • Tuberculosis test, gamma interferon (HCPCS:86480)
  • Hemoglobin a1c level (HCPCS:83036)
  • Limited ultrasound scan of joint or other extremity structure lacking blood vessels (HCPCS:76882)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Ldl cholesterol level (HCPCS:83721)
  • Nucleotidase 5' (enzyme) level (HCPCS:83915)
  • Bilirubin level, total (HCPCS:82247)
  • Bilirubin level, direct (HCPCS:82248)
  • Urinalysis, manual test (HCPCS:81002)
  • Interpretation of trabecular bone score (tbs) and report on fracture risk (HCPCS:77092)
  • Injection of trigger points, 1-2 muscles (HCPCS:20552)
  • Rheumatoid factor level (HCPCS:86431)
  • X-ray of shoulder, minimum of 2 views (HCPCS:73030)
  • Collagen cross links test, (urine test to evaluate bone health) (HCPCS:82523)
  • Creatine measurement (HCPCS:82540)
  • X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
  • X-ray of both hips, 2 views (HCPCS:73521)

The enumeration date for this NPI number is 6/5/2014 and was last updated on 10/23/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology292739NEW YORKYes
2390200000XStudent in an Organized Health Care Education/Training ProgramNo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.